
Asrazone S 500mg/500mg Injection
Marketer
Asrawell Lifecare
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Asrazone S 500mg/500mg Injection
Combiflox 500mg/500mg injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under a physician's guidance; consistent adherence to the prescribed regimen is crucial for optimal efficacy, even with symptom improvement. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical consultation. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require urgent medical attention. Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are vital for recovery. Your doctor may order tests to monitor treatment response.
Uses of Asrazone S 500mg/500mg Injection
Managing bacterial infections
Major Benefits of Asrazone S 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Asrazone S 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Asrazone S 500mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Asrazone S 500mg/500mg Injection works:
Asrazone S Injection, containing 500mg each of Cefoperazone and Sulbactam, employs a dual-action approach to bacterial infection. Cefoperazone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Asrazone S 500mg/500mg Injection treatment can trigger adverse reactions including facial redness, rapid pulse, vomiting, dehydration, angina, and hypotension (a disulfiram-like effect).
PregnancySAFE IF PRESCRIBED
The injectable medication Asrazone S 500mg/500mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to offspring; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Asrazone S 500mg/500mg is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the drug into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Asrazone S 500mg/500mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Asrazone S 500mg/500mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Asrazone S 500mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Asrazone S 500mg/500mg Injection :
Should you inadvertently skip a dose of Asrazone S 500mg/500mg Injection, seek immediate medical advice.
Facts to Know About Asrazone S 500mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Agents against infection |
